MedTrace Logo

Development and Feasibility Testing of DM-BOOST Intervention.

NCT04710940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-02-22

No results posted yet for this study

Summary

DM-BOOST uses clinical informatics tools to identify types of patients with gaps in diabetes care and deploy tailored, proactive outreach methods rooted in behavioral economics to nudge them towards increased engagement with diabetes self-management training and leverage patient-facing technologies to enhance longitudinal patient self-management support.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Diabetes BOOST

Participants will receive supportive care using technology for DSMT in addition to usual care.

BEHAVIORAL

Usual Care

Participants will receive usual care for DSMT.

Sponsors & Collaborators

  • Worcester Polytechnic Institute

    collaborator OTHER

  • Daniel Amante

    lead OTHER

Principal Investigators

  • Daniel J Amante, PhD, MPH · UMass Medical School

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-13
Primary Completion
2022-11-01
Completion
2024-01-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710940 on ClinicalTrials.gov